Kangji Medical Holdings Statistics

Total Valuation

FRA:50J has a market cap or net worth of EUR 973.24 million. The enterprise value is 829.88 million.

Market Cap	973.24M
Enterprise Value	829.88M

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	May 27, 2025

Share Statistics

Current Share Class	1.21B
Shares Outstanding	n/a
Shares Change (YoY)	+0.29%
Shares Change (QoQ)	+0.67%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	351.80M

Valuation Ratios

The trailing PE ratio is 12.65.

PE Ratio	12.65
Forward PE	n/a
PS Ratio	7.29
PB Ratio	2.80
P/TBV Ratio	2.80
P/FCF Ratio	14.57
P/OCF Ratio	13.13
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.14, with an EV/FCF ratio of 12.42.

EV / Earnings	10.79
EV / Sales	7.11
EV / EBITDA	13.14
EV / EBIT	13.83
EV / FCF	12.42

Financial Position

The company has a current ratio of 7.92, with a Debt / Equity ratio of 0.00.

Current Ratio	7.92
Quick Ratio	6.19
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	849.55

Financial Efficiency

Return on equity (ROE) is 17.38% and return on invested capital (ROIC) is 10.20%.

Return on Equity (ROE)	17.38%
Return on Assets (ROA)	9.40%
Return on Invested Capital (ROIC)	10.20%
Return on Capital Employed (ROCE)	20.33%
Revenue Per Employee	132,543
Profits Per Employee	76,408
Employee Count	1,007
Asset Turnover	0.28
Inventory Turnover	1.98

Taxes

In the past 12 months, FRA:50J has paid 15.03 million in taxes.

Income Tax	15.03M
Effective Tax Rate	16.58%

Stock Price Statistics

The stock price has increased by +21.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.54%
50-Day Moving Average	0.83
200-Day Moving Average	0.77
Relative Strength Index (RSI)	51.49
Average Volume (20 Days)	569

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:50J had revenue of EUR 133.47 million and earned 76.94 million in profits. Earnings per share was 0.07.

Revenue	133.47M
Gross Profit	105.55M
Operating Income	71.50M
Pretax Income	90.62M
Net Income	76.94M
EBITDA	74.45M
EBIT	71.50M
Earnings Per Share (EPS)	0.07

Full Income Statement

Balance Sheet

The company has 164.42 million in cash and 465,145 in debt, giving a net cash position of 163.96 million.

Cash & Cash Equivalents	164.42M
Total Debt	465,145
Net Cash	163.96M
Net Cash Per Share	n/a
Equity (Book Value)	347.89M
Book Value Per Share	0.29
Working Capital	238.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 74.12 million and capital expenditures -7.32 million, giving a free cash flow of 66.80 million.

Operating Cash Flow	74.12M
Capital Expenditures	-7.32M
Free Cash Flow	66.80M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 79.08%, with operating and profit margins of 53.57% and 57.65%.

Gross Margin	79.08%
Operating Margin	53.57%
Pretax Margin	67.90%
Profit Margin	57.65%
EBITDA Margin	55.78%
EBIT Margin	53.57%
FCF Margin	50.05%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.71%.

Dividend Per Share	0.03
Dividend Yield	3.71%
Dividend Growth (YoY)	-83.82%
Years of Dividend Growth	4
Payout Ratio	283.32%
Buyback Yield	-0.29%
Shareholder Yield	3.42%
Earnings Yield	7.91%
FCF Yield	6.86%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:50J has an Altman Z-Score of 16.57 and a Piotroski F-Score of 4.

Altman Z-Score	16.57
Piotroski F-Score	4